31 reports

MARKET ##.

  • Chemokine
  • APAC
  • Europe
  • Japan
  • World
  • C-C Chemokine Receptor Type 4 (C-C CKR-4 or K5-5 or CD194 or CCR4) - Drug Profiles
  • C-C Chemokine Receptor Type 4 (C-C CKR-4 or K5-5 or CD194 or CCR4) - Dormant Projects

C-C Chemokine Receptor Type 4 (K5-5 or CD194 or CCR4) - Pipeline Review, H1 2018 Summary C-C Chemokine Receptor Type 4 (K5-5 or CD194 or CCR4) - C-C chemokine receptor type 4 is a protein encoded by the CCR4 gene. CCR4 is expressed on Th2 T lymphocytes and is up-regulated by T cell receptor activation....

  • Chemokine
  • Therapy
  • United States
  • World
  • Kyowa Hakko Kirin Co., Ltd.
  • C-C Chemokine Receptor Type 4 (K5-5 or CD194 or CCR4) - Discontinued Products
  • C-C Chemokine Receptor Type 4 (K5-5 or CD194 or CCR4) - Overview

C-C Chemokine Receptor Type 4 (K5-5 or CD194 or CCR4) - Pipeline Review, H2 2017 Summary C-C Chemokine Receptor Type 4 (K5-5 or CD194 or CCR4) - C-C chemokine receptor type 4 is a protein encoded by the CCR4 gene. CCR4 is expressed on Th2 T lymphocytes and is up-regulated by T cell receptor activation. This receptor...

  • Chemokine
  • Therapy
  • United States
  • World
  • Kyowa Hakko Kirin Co., Ltd.
  • DF-2755A - DRUG PROFILE
  • NUMBER OF PRODUCTS BY STAGE AND MECHANISM OF ACTIONS, H1 2018

C-X-C Chemokine Receptor Type 1 (CDw128a or High Affinity Interleukin 8 Receptor A or IL8 Receptor Type 1 or CD181 or CXCR1) - Pipeline Review, H1 2018 Summary According to the recently published report ’C-X-C Chemokine Receptor Type 1 - Pipeline Review, H1 2018’; C-X-C Chemokine Receptor Type 1...

  • Breast Cancer
  • Chemokine
  • Cytokine
  • Therapy
  • Dompe Farmaceutici S.p.A.
  • DISCONTINUED PRODUCTS, H1 2018
  • AZD-5069 - DRUG PROFILE

C-X-C Chemokine Receptor Type 2 (CDw128b or GRO/MGSA Receptor or High Affinity Interleukin 8 Receptor B or IL8 Receptor Type 2 or CD182 or CXCR2) - Pipeline Review, H1 2018 Summary C-X-C Chemokine Receptor Type 2 (CDw128b or GRO/MGSA Receptor or High Affinity Interleukin 8 Receptor B or IL8 Receptor...

  • Chemokine
  • General Medicine And Specialty Medicine
  • United States
  • World
  • Product Initiative
  • NUMBER OF PRODUCTS BY STAGE AND MECHANISM OF ACTIONS, H1 2018
  • GLOBAL MARKETS DIRECT REPORT COVERAGE

C-C Chemokine Receptor Type 1 (HM145 or LD78 Receptor or Macrophage Inflammatory Protein 1 Alpha Receptor or RANTES R or CD191 or CCR1) - Pipeline Review, H1 2018 Summary C-C Chemokine Receptor Type 1 (HM145 or LD78 Receptor or Macrophage Inflammatory Protein 1 Alpha Receptor or RANTES R or CD191...

  • Chemokine
  • Therapy
  • World
  • Product Initiative
  • ChemoCentryx, Inc.
  • GLOBAL MARKETS DIRECT REPORT COVERAGE
  • DEC 16, 2009: CHEMOCENTRYX INITIATES PHASE 2 CLINICAL TRIAL OF CCX354 FOR THE TREATMENT OF RHEUMATOID ARTHRITIS

C-C Chemokine Receptor Type 1 (HM145 or LD78 Receptor or Macrophage Inflammatory Protein 1 Alpha Receptor or RANTES R or CD191 or CCR1) - Pipeline Review, H2 2017 Summary C-C Chemokine Receptor Type 1 (HM145 or LD78 Receptor or Macrophage Inflammatory Protein 1 Alpha Receptor or RANTES R or CD191 or CCR1) pipeline Target...

  • Chemokine
  • Therapy
  • United States
  • World
  • ChemoCentryx, Inc.
  • DF-2755A - DRUG PROFILE
  • NUMBER OF PRODUCTS BY STAGE AND MECHANISM OF ACTIONS, H2 2017

C-X-C Chemokine Receptor Type 1 (CDw128a or High Affinity Interleukin 8 Receptor A or IL8 Receptor Type 1 or CD181 or CXCR1) - Pipeline Review, H2 2017 Summary According to the recently published report ’C-X-C Chemokine Receptor Type 1 - Pipeline Review, H2 2017’; C-X-C Chemokine Receptor Type 1 (CDw128a or High Affinity...

  • Chemokine
  • Cytokine
  • Therapy
  • Transplantation
  • Dompe Farmaceutici S.p.A.
  • DISCONTINUED PRODUCTS, H2 2017
  • DORMANT PRODUCTS, H2 2017

Stromal Cell Derived Factor 1 (C-X-C Motif Chemokine 12 or Intercrine Reduced In Hepatomas or SDF1 or Pre B Cell Growth Stimulating Factor or CXCL12) - Pipeline Review, H2 2017 Summary Stromal Cell Derived Factor 1 (C-X-C Motif Chemokine 12 or Intercrine Reduced In Hepatomas or SDF1 or Pre B Cell Growth Stimulating...

  • Chemokine
  • Hospital
  • Pharmaceutical
  • Therapy
  • Juventas Therapeutics, Inc.
  • R&D Progress Research and Development Brief
  • DISCONTINUED PRODUCTS, H2 2017

C-X-C Chemokine Receptor Type 2 (CDw128b or GRO/MGSA Receptor or High Affinity Interleukin 8 Receptor B or IL8 Receptor Type 2 or CD182 or CXCR2) – Pipeline Review, H2 2017 Summary C-X-C Chemokine Receptor Type 2 (CDw128b or GRO/MGSA Receptor or High Affinity Interleukin 8 Receptor B or IL8 Receptor Type 2 or CD182...

  • Chemokine
  • Therapy
  • United States
  • World
  • Product Initiative
  • CCX-650 - DRUG PROFILE
  • CHEMOCENTRYX INC

Atypical Chemokine Receptor 3 (C-X-C Chemokine Receptor Type 7 or Chemokine Orphan Receptor 1 or G Protein Coupled Receptor 159 or G Protein Coupled Receptor RDC1 Homolog or GPR159 or CXCR7 or ACKR3) - Pipeline Review, H2 2017 Summary According to the recently published report ’Atypical Chemokine Receptor - Pipeline...

  • Chemokine
  • Therapy
  • United States
  • Product Initiative
  • ChemoCentryx, Inc.
  • C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) - Overview
  • C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) - Therapeutics Development

C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) - Pipeline Review, H1 2018 Summary C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) - C-C chemokine receptor type 5 (CCR5) also known as CD195, is a surface protein located on the...

  • Chemokine
  • United States
  • Company
  • Product Initiative
  • CytoDyn Inc.
  • C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) - Dormant Products
  • C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) - Overview

C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) – Pipeline Review, H2 2017 Summary C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) pipeline Target constitutes close to 15 molecules. Out of which approximately 12 molecules are developed by companies...

  • Chemokine
  • HIV AIDS
  • Therapy
  • United States
  • Product Initiative
  • C-C Chemokine Receptor Type 3 (Eosinophil Eotaxin Receptor or CD193 or CCR3) - Products under Development by Therapy Area
  • C-C Chemokine Receptor Type 3 (Eosinophil Eotaxin Receptor or CD193 or CCR3) - Pipeline Products Glance

C-C Chemokine Receptor Type 3 (Eosinophil Eotaxin Receptor or CD193 or CCR3) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘C-C Chemokine Receptor Type 3 (Eosinophil Eotaxin Receptor or CD193 or CCR3) - Pipeline Review, H2 2016’, provides in depth analysis on C-C Chemokine Receptor Type 3 (Eosinophil Eotaxin...

  • Chemokine
  • Chronic Disease
  • World
  • Product Initiative
  • Pharmaxis Ltd
  • CCX-771 - DRUG PROFILE
  • PRODUCTS UNDER DEVELOPMENT BY UNIVERSITIES/INSTITUTES

Atypical Chemokine Receptor 3 (C-X-C Chemokine Receptor Type 7 or Chemokine Orphan Receptor 1 or G Protein Coupled Receptor 159 or G Protein Coupled Receptor RDC1 Homolog or GPR159 or CXCR7 or ACKR3) - Pipeline Review, H1 2018 Summary Atypical Chemokine Receptor 3 (C-X-C Chemokine Receptor Type 7...

  • Chemokine
  • Pharmaceutical
  • United States
  • World
  • Product Initiative
  • C-C Chemokine Receptor Type 3 (C-C CKR-3 or Eosinophil Eotaxin Receptor or CD193 or CCR3) Overview
  • C-C Chemokine Receptor Type 3 (C-C CKR-3 or Eosinophil Eotaxin Receptor or CD193 or CCR3) - Dormant Projects

C-C Chemokine Receptor Type 3 (C-C CKR-3 or Eosinophil Eotaxin Receptor or CD193 or CCR3) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘C-C Chemokine Receptor Type 3 (C-C CKR-3 or Eosinophil Eotaxin Receptor or CD193 or CCR3) - Pipeline Review, H1 2016’, provides in depth analysis on C-C Chemokine Receptor...

  • Chemokine
  • Turkey
  • World
  • Product Initiative
  • Pharmaxis Ltd
  • C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) - Dormant Projects
  • C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) - Pipeline Products Glance

C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) - Pipeline Review, H2 2016’, provides in depth analysis on C-C Chemokine Receptor Type 5 (CHEMR13...

  • Chemokine
  • HIV AIDS
  • United States
  • Product Initiative
  • Tobira Therapeutics, Inc.
  • DISCONTINUED PRODUCTS, H1 2016
  • NUMBER OF PRODUCTS BY STAGE AND MECHANISM OF ACTION, H1 2016

C-X-C Chemokine Receptor Type 2 (CDw128b or GRO/MGSA Receptor or High Affinity Interleukin-8 Receptor B or IL-8 Receptor Type 2 or CD182 or CXCR2) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘C-X-C Chemokine Receptor Type 2 (CDw128b or GRO/MGSA Receptor or High Affinity Interleukin-8 Receptor B or IL-8...

  • Chemokine
  • United States
  • World
  • Product Initiative
  • Dompe Farmaceutici S.p.A.
  • DF-2755A - Drug Profile
  • Global Markets Direct Report Coverage

C-X-C Chemokine Receptor Type 1 (CDw128a or High Affinity Interleukin-8 Receptor A or IL-8 Receptor Type 1 or CD181 or CXCR1) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘C-X-C Chemokine Receptor Type 1 (CDw128a or High Affinity Interleukin-8 Receptor A or IL-8 Receptor Type 1 or CD181 or CXCR1) - Pipeline...

  • Chemokine
  • United States
  • World
  • Product Initiative
  • Dompe Farmaceutici S.p.A.
  • BMS-457 - DRUG PROFILE
  • NUMBER OF PRODUCTS UNDER DEVELOPMENT BY INDICATION, H1 2016

C-C Chemokine Receptor Type 1 (HM145 or LD78 Receptor or Macrophage Inflammatory Protein 1-Alpha Receptor or CD191 or CCR1) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘C-C Chemokine Receptor Type 1 (HM145 or LD78 Receptor or Macrophage Inflammatory Protein 1-Alpha Receptor or CD191 or CCR1) - Pipeline...

  • Chemokine
  • Therapy
  • United States
  • Product Initiative
  • ChemoCentryx, Inc.
  • NUMBER OF PRODUCTS UNDER DEVELOPMENT BY COMPANIES, H2 2016
  • DISCONTINUED PRODUCTS, H2 2016

C-X-C Chemokine Receptor Type 2 (CDw128b or GRO/MGSA Receptor or High Affinity Interleukin 8 Receptor B or IL8 Receptor Type 2 or CD182 or CXCR2) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘C-X-C Chemokine Receptor Type 2 (CDw128b or GRO/MGSA Receptor or High Affinity Interleukin 8 Receptor B or IL8 Receptor...

  • Chemokine
  • Cytokine
  • United States
  • Product Initiative
  • Dompe Farmaceutici S.p.A.
  • DORMANT PRODUCTS, H1 2018
  • DORMANT PROJECTS, H1 2016

Stromal Cell Derived Factor 1 (C-X-C Motif Chemokine 12 or Intercrine Reduced In Hepatomas or SDF1 or Pre B Cell Growth Stimulating Factor or CXCL12) - Pipeline Review, H1 2018 Summary Stromal Cell Derived Factor 1 (C-X-C Motif Chemokine 12 or Intercrine Reduced In Hepatomas or SDF1 or Pre B Cell...

  • Chemokine
  • Therapy
  • United States
  • World
  • Product Initiative
  • PRODUCTS UNDER DEVELOPMENT BY STAGE OF DEVELOPMENT
  • BALIXAFORTIDE - DRUG PROFILE

CXCR-## is an alpha chemokine receptor specific for stromal-derived-factor-##.

  • Cancer
  • Chemokine
  • United States
  • Product Initiative
  • BioLineRx Ltd.
  • The BL-8040 oncology platform is a short cyclic peptide that functions as a high-affinity antagonist for CXCR4, a chemokine receptor that is directly involved in tumor progression, angiogenesis, metastasis and cell survival.
  • DORMANT PROJECTS, H2 2016

C-X-C Chemokine Receptor Type 4 (FB22 or Fusin or HM89 or LCR1 or Leukocyte Derived Seven Transmembrane Domain Receptor or Lipopolysaccharide Associated Protein 3 or Stromal Cell Derived Factor 1 Receptor or NPYRL or CD184 or CXCR4) - Pipeline Review, H2 Summary Global Markets Direct’s, ‘C-X-C Chemokine Receptor Type...

  • Chemokine
  • Renal Cancer
  • Research And Development
  • Therapy
  • BioLineRx Ltd.
  • DORMANT PROJECTS, H1 2016
  • CCX-650 - DRUG PROFILE

Atypical Chemokine Receptor 3 (Chemokine Orphan Receptor 1 or G-Protein Coupled Receptor 159 or G-Protein Coupled Receptor RDC1 Homolog or GPR159 or CXCR7) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Atypical Chemokine Receptor 3 (Chemokine Orphan Receptor 1 or G-Protein Coupled Receptor 159 or G-Protein...

  • Chemokine
  • Turkey
  • United States
  • World
  • ChemoCentryx, Inc.
  • NUMBER OF PRODUCTS UNDER DEVELOPMENT BY COMPANIES, H1 2016
  • NUMBER OF PRODUCTS BY STAGE AND MECHANISM OF ACTION, H1 2016

C-C Chemokine Receptor Type 5 (C-C CKR-5 or CHEMR13 or HIV-1 Fusion Coreceptor or CD195 or CCR5) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘C-C Chemokine Receptor Type 5 (C-C CKR-5 or CHEMR13 or HIV-1 Fusion Coreceptor or CD195 or CCR5) - Pipeline Review, H1 2016’, provides in depth analysis on C-C Chemokine...

  • Chemokine
  • HIV AIDS
  • United States
  • World
  • Product Initiative
  • Mechanism Of Action
  • (FILGRASTIM + PLERIXAFOR) - DRUG PROFILE

C-X-C Chemokine Receptor Type 4 (Fusin or Leukocyte-Derived Seven Transmembrane Domain Receptor or Lipopolysaccharide-Associated Protein 3 or Stromal Cell-Derived Factor 1 Receptor or CD184 or CXCR4) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘C-X-C Chemokine Receptor Type 4 (Fusin or Leukocyte-Derived...

  • Chemokine
  • HIV AIDS
  • Research And Development
  • Therapy
  • BioLineRx Ltd.
  • 7.7 PIPELINE PROGRAMS TARGETING C-C MOTIF CHEMOKINE 4 (CCL4) AND C-C MOTIF CHEMOKINE 5 (CCL5)
  • Rheumatoid Arthritis, Global, Key Features and Pipeline Activity of C-X-C Motif Chemokine 13, 2016

Frontier Pharma: Rheumatoid Arthritis - Cytokine Mediators and Kinase Inhibitors Dominate First-in-Class Product Innovation Summary Rheumatoid Arthritis (RA) is a chronic, progressive and currently incurable auto-immune disease that affects the joints, and is characterized by synovial inflammation and hyperplasia. It occurs...

  • Arthritis
  • Chemokine
  • Pathology
  • World
  • Deals & Alliance

Boehringer Sohn AG & Co KG ## ## ## ## ## ## Nitto Denko Corp ## ## ## ## ## ## Galectin Therapeutics Inc ## ## ## ## ## ## F.

  • Chemokine
  • Clinical Trial
  • Drug Discovery And Development
  • World
  • Product Initiative
  • List of Tables
  • Jyant Technologies, Inc. - Pipeline Products by Mechanism of Action, 2016

Jyant Technologies, Inc. - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘Jyant Technologies, Inc. - Product Pipeline Review - 2016’, provides an overview of the Jyant Technologies, Inc.’s pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics...

  • Chemokine
  • Research And Development
  • United States
  • Company Operations
  • Jyant Technologies Inc